Ankündigung • Jun 30
Shanghai GenTech Co., Ltd. to Report First Half, 2026 Results on Aug 27, 2026 Shanghai GenTech Co., Ltd. announced that they will report first half, 2026 results on Aug 27, 2026 Board Change • May 20
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Jiamao Cheng was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Ankündigung • Apr 17
Shanghai GenTech Co., Ltd., Annual General Meeting, May 08, 2026 Shanghai GenTech Co., Ltd., Annual General Meeting, May 08, 2026, at 15:00 China Standard Time. Location: The Company's Meeting Room, Shanghai China Ankündigung • Mar 30
Shanghai GenTech Co., Ltd. to Report Q1, 2026 Results on Apr 18, 2026 Shanghai GenTech Co., Ltd. announced that they will report Q1, 2026 results on Apr 18, 2026 Ankündigung • Dec 26
Shanghai GenTech Co., Ltd. to Report Fiscal Year 2025 Results on Apr 18, 2026 Shanghai GenTech Co., Ltd. announced that they will report fiscal year 2025 results on Apr 18, 2026 Ankündigung • Sep 30
Shanghai GenTech Co., Ltd. to Report Q3, 2025 Results on Oct 31, 2025 Shanghai GenTech Co., Ltd. announced that they will report Q3, 2025 results on Oct 31, 2025 Ankündigung • Jun 30
Shanghai GenTech Co., Ltd. to Report First Half, 2025 Results on Aug 30, 2025 Shanghai GenTech Co., Ltd. announced that they will report first half, 2025 results on Aug 30, 2025 Ankündigung • May 23
Shanghai GenTech Co., Ltd., Annual General Meeting, Jun 13, 2025 Shanghai GenTech Co., Ltd., Annual General Meeting, Jun 13, 2025, at 13:30 China Standard Time. Location: The Company's Meeting Room, Shanghai China Ankündigung • Mar 28
Shanghai GenTech Co., Ltd. to Report Q1, 2025 Results on Apr 29, 2025 Shanghai GenTech Co., Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025 Ankündigung • Dec 27
Shanghai GenTech Co., Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025 Shanghai GenTech Co., Ltd. announced that they will report fiscal year 2024 results on Apr 29, 2025 Ankündigung • Dec 06
Shanghai GenTech Co., Ltd. (SHSE:688596) agreed to acquire an additional 30.50% stake in Hongge Semiconductor Equipment (Shanghai) Co., Ltd. from LIU ERZHUANG, Tian Linlin, Hong Kong Fengge, Xu Zhiyong, Jiehongye, and Zhang Xiaomei for approximately CNY 340 million. Shanghai GenTech Co., Ltd. (SHSE:688596) agreed to acquire an additional 30.50% stake in Hongge Semiconductor Equipment (Shanghai) Co., Ltd. from LIU ERZHUANG, Tian Linlin, Hong Kong Fengge Co., Ltd., Xu Zhiyong, Jiehongye Co., Ltd., and Zhang Xiaomei for approximately CNY 340 million on December 3, 2024. Upon completion, Shanghai GenTech Co., Ltd. will own 90.50% stake in Hongge Semiconductor Equipment (Shanghai) Co., Ltd. The transaction will be financed through equity investment of CNY 335.67 million. As of September 30, 2024, Hongge Semiconductor Equipment (Shanghai) Co., Ltd. reported total assets of CNY 747.01 million and total common equity of CNY 392.61 million. The transaction is subject to approval of offer by acquirer board. The deal has been approved by the board. Reported Earnings • Oct 31
Third quarter 2024 earnings released: EPS: CN¥0.80 (vs CN¥0.45 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.80 (up from CN¥0.45 in 3Q 2023). Revenue: CN¥1.65b (up 55% from 3Q 2023). Net income: CN¥226.7m (up 88% from 3Q 2023). Profit margin: 14% (up from 11% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 23% growth forecast for the Semiconductor industry in China. Valuation Update With 7 Day Price Move • Oct 15
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to CN¥32.48, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 32x in the Semiconductor industry in China. Total loss to shareholders of 14% over the past year. Ankündigung • Sep 30
Shanghai GenTech Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024 Shanghai GenTech Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024 Valuation Update With 7 Day Price Move • Sep 28
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CN¥29.41, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 29x in the Semiconductor industry in China. Total loss to shareholders of 21% over the past year. New Risk • Sep 09
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (33% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.8% average weekly change). Shareholders have been diluted in the past year (3.1% increase in shares outstanding). Reported Earnings • Aug 30
Second quarter 2024 earnings released: EPS: CN¥0.29 (vs CN¥0.53 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.29 (down from CN¥0.53 in 2Q 2023). Revenue: CN¥1.26b (up 35% from 2Q 2023). Net income: CN¥80.0m (down 42% from 2Q 2023). Profit margin: 6.3% (down from 15% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Semiconductor industry in China. Valuation Update With 7 Day Price Move • Jul 26
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥28.50, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 30x in the Semiconductor industry in China. Total loss to shareholders of 17% over the past year. Ankündigung • Jul 09
Shanghai GenTech Co., Ltd. (SHSE:688596) announces an Equity Buyback for CNY 50 million worth of its shares. Shanghai GenTech Co., Ltd. (SHSE:688596) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be purchased at a price not exceeding CNY 40 per share. The purpose of the program is to establish and improve the company's long-term incentive mechanism, fully mobilize the enthusiasm of the company's employees, effectively combine the interests of shareholders, the company and the personal interests of employees, and promote the healthy and sustainable development of the company. The repurchased shares will be used for employee stock ownership plans or equity incentive plans, otherwise will be cancelled if the company fails to transfer them within the time limit stipulated by relevant laws and regulations. The program will be funded from company's own funds. The program will be valid for 6 months. Ankündigung • Jun 28
Shanghai GenTech Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024 Shanghai GenTech Co., Ltd. announced that they will report first half, 2024 results on Aug 30, 2024 Reported Earnings • May 01
First quarter 2024 earnings released: EPS: CN¥0.09 (vs CN¥0.04 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.09 (up from CN¥0.04 in 1Q 2023). Revenue: CN¥588.7m (up 43% from 1Q 2023). Net income: CN¥24.9m (up 123% from 1Q 2023). Profit margin: 4.2% (up from 2.7% in 1Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 30% p.a. on average during the next 2 years, compared to a 23% growth forecast for the Semiconductor industry in China. Ankündigung • May 01
Shanghai GenTech Co., Ltd., Annual General Meeting, May 24, 2024 Shanghai GenTech Co., Ltd., Annual General Meeting, May 24, 2024, at 13:30 China Standard Time. Location: The Company's Meeting Room, Shanghai China Board Change • Apr 17
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Yue Liu was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Ankündigung • Mar 30
Shanghai GenTech Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024 Shanghai GenTech Co., Ltd. announced that they will report Q1, 2024 results on Apr 30, 2024 Reported Earnings • Feb 24
Full year 2023 earnings released: EPS: CN¥1.47 (vs CN¥1.01 in FY 2022) Full year 2023 results: EPS: CN¥1.47 (up from CN¥1.01 in FY 2022). Revenue: CN¥3.84b (up 42% from FY 2022). Net income: CN¥401.7m (up 55% from FY 2022). Profit margin: 11% (in line with FY 2022). Revenue is forecast to grow 28% p.a. on average during the next 2 years, compared to a 24% growth forecast for the Semiconductor industry in China. Ankündigung • Feb 08
Shanghai GenTech Co., Ltd. (SHSE:688596) announces an Equity Buyback for CNY 50 million worth of its shares. Shanghai GenTech Co., Ltd. (SHSE:688596) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its A shares. The shares will be repurchased at a price not more than CNY 40 per share. The repurchased shares will all be used for employee stock ownership plans or equity incentives. The company will use its own funds or self-raised funds to repurchase its shares. The program is valid for 6 months. New Risk • Feb 06
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.4% average weekly change). Large one-off items impacting financial results. Shareholders have been diluted in the past year (2.4% increase in shares outstanding). Valuation Update With 7 Day Price Move • Feb 01
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥30.88, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 25x in the Semiconductor industry in China. Reported Earnings • Oct 26
Third quarter 2023 earnings released: EPS: CN¥0.45 (vs CN¥0.33 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.45 (up from CN¥0.33 in 3Q 2022). Revenue: CN¥1.07b (up 24% from 3Q 2022). Net income: CN¥120.8m (up 43% from 3Q 2022). Profit margin: 11% (up from 9.8% in 3Q 2022). Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 25% growth forecast for the Semiconductor industry in China. Reported Earnings • Aug 25
Second quarter 2023 earnings released: EPS: CN¥0.52 (vs CN¥0.19 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.52 (up from CN¥0.19 in 2Q 2022). Revenue: CN¥933.6m (up 61% from 2Q 2022). Net income: CN¥138.6m (up 234% from 2Q 2022). Profit margin: 15% (up from 7.2% in 2Q 2022). Revenue is forecast to grow 29% p.a. on average during the next 3 years, compared to a 24% growth forecast for the Semiconductor industry in China. Reported Earnings • Apr 26
First quarter 2023 earnings released: EPS: CN¥0.04 (vs CN¥0.04 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.04 (in line with 1Q 2022). Revenue: CN¥410.8m (up 13% from 1Q 2022). Net income: CN¥11.1m (down 1.0% from 1Q 2022). Profit margin: 2.7% (down from 3.1% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 30% p.a. on average during the next 2 years, compared to a 24% growth forecast for the Semiconductor industry in China. Valuation Update With 7 Day Price Move • Apr 03
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CN¥39.90, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 39x in the Semiconductor industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥24.05 per share. Board Change • Mar 15
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Jay Chen was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. 
